The ameliorative potential of Hyphaene thebaica on streptozotocin-induced diabetic nephropathy

• Autorzy: AbdEl-moniem M. , Mustafa H.N. , Megahed H.A. , Agaibyi M.H. , Hegazy G.A. , El-Dabaa M.A.
• Języki publikacji: EN

Abstrakty

EN

Background: Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. The aim of the current study is to investigate the possible beneficial effects of Hyphaene thebaica in DN. Materials and methods: For this, 50 male albino rats were divided into five groups: group I — represented the control group; group II — received Hyphaene thebaica extracts of 150 mg/kg BW by oral gavage for 6 weeks; group III — received single intraperitoneal injections of streptozotocin (50 mg/kg BW) to induce type-2 diabetes mellitus; group IV (protective) — diabetic rats received Hyphaene thebaica extract (150 mg/kg BW) orally for 6 weeks; group V (curative) — received Hyphaene thebaica extract (150 mg/kg BW) orally after the diagnosis of DN. Results: In the DN protected group, blood glucose, urea, and creatinine decreased significantly, while insulin and C-peptide increased significantly. Moreover, cystatin C and neutrophil gelatinase-associated lipocalin decreased. Collagen fibre deposition is increased with an apparent thickening of the parietal layer of Bowman’s capsules and the basal lamina of convoluted tubules, as well as increase of the immune-reaction of caspase-3 and desmin. The introduction of Hyphaene thebaica led to greater amelioration in the biochemical markers, apoptotic alterations, and podocyte injuries of the protected group than in the curative group. Conclusions: Hyphaene thebaica may be advised as a good choice that can delay diabetic renal complications. (Folia Morphol 2015; 74, 4: 447–457)

• Wydawca: -
• Czasopismo: Folia Morphologica
• Rocznik: 2015
• Tom: 74
• Numer: 4
• Opis fizyczny: p.447-457,fig.,ref.

Twórcy

autor

AbdEl-moniem M.

• Medical Biochemistry Department, National Research Centre, Cairo, Egypt

autor

Mustafa H.N.

• Anatomy Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

autor

Megahed H.A.

• Medical Biochemistry Department, National Research Centre, Cairo, Egypt

autor

Agaibyi M.H.

• Medical Biochemistry Department, National Research Centre, Cairo, Egypt

autor

Hegazy G.A.

• Medical Biochemistry Department, National Research Centre, Cairo, Egypt
• Clinical Biochemistry Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

autor

El-Dabaa M.A.

• Botany Department, National Research Centre, Cairo, Egypt

Bibliografia

• 1. Abdel-Rahim EA, El-Beltagi H, Fayed A (2011) Comparative studies on the influences of Juniperus phoenicea and Hyphaena thebaica as hypoglycemic factors in diabetic rats. J Advanc Food Scien, 33: 128–132.
• 2. Al-Masri SA, Riyadh SA (2012) Effect of doum and methionine combination on hepatotoxicity in rats. Australian J Basic Applied Scien, 6: 392–397.
• 3. Aremu A, Fadele O (2011) Study of some properties of doum palm fruit (Hyphaene thebaica Mart.) in relation to moisture content. Afr J Agricult Res, 6: 3597–3602.
• 4. Arumugam S, Sreedhar R, Miyashita S, Karuppagounder V, Thandavarayan RA, Giridharan VV, Pitchaimani V, Afrin R, Harima M, Suzuki K (2014) Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy. Exp Mol Pathol, 97: 137–143.
• 5. Assal HS, Tawfeek S, Rasheed EA, El-Lebedy D, Thabet EH (2013) Serum cystatin C and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitus. Clin Med Insights Endocrinol Diabetes, 6: 7–13.
• 6. Balakumar P, Chakkarwar VA, Kumar V, Jain A, Reddy J, Singh M (2008) Experimental models for nephropathy. J Renin Angiotensin Aldosterone Syst, 9: 189–195.
• 7. Benigni A, Gagliardini E, Tomasoni S, Abbate M, Ruggenenti P, Kalluri R, Remuzzi G (2004) Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int, 65: 2193–2200.
• 8. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, Nicocia G, Buemi M (2009) Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res, 32: 91–98.
• 9. Dronavalli S, Duka I, Bakris GL (2008) The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab, 4: 444–452.
• 10. El-Aouni C, Herbach N, Blattner SM, Henger A, Rastaldi MP, Jarad G, Miner JH, Moeller MJ, St-Arnaud R, Dedhar S, Holzman LB, Wanke R, Kretzler M (2006) Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. J Am Soc Nephrol, 17: 1334–1344.
• 11. El-Asrar AMA, Dralands L, Missotten L, Al-Jadaan IA, Geboes K (2004) Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Visual Scien, 45: 2760–2766.
• 12. Elmarakby AA, Sullivan JC (2012) Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther, 30: 49–59.
• 13. Fioretto P, Mauer M (2007) Histopathology of diabetic nephropathy. Semin Nephrol, 27: 195–207.
• 14. Flynn ER, Lee J, Hutchens ZM Jr, Chade AR, Maric-Bilkan C (2013) C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic rat. J Diabetes Complications, 27: 538–547.
• 15. Hsu B, Coupar IM, Ng K (2006) Antioxidant activity of hot water extract from the fruit of the Doum palm, Hyphaene thebaica. Food Chem, 98: 317–328.
• 16. Hussein AM, Saleh HA, Mustafa HN (2014) Effect of sodium selenite and vitamin E on the renal cortex in rats: an ultrastructure study. Tissue Cell, 46: 170–177.
• 17. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med, 367: 20–29.
• 18. Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M (2011) Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA, 305: 2432–2439.
• 19. Kanasaki K, Taduri G, Koya D (2013) Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis. Front Endocrinol (Lausanne), 4: 7.
• 20. Kim EH, Yu JH, Lee SA, Kim EY, Kim WG, Lee SH, Cho EH, Koh EH, Lee WJ, Kim MS, Park JY, Lee KU (2010) Lack of association between serum cystatin C levels and coronary artery disease in diabetic patients. Korean Diabetes J, 34: 95–100.
• 21. Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, Kwak IS, Kim YK (2012) Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract, 97: 251–257.
• 22. Kumar D, Zimpelmann J, Robertson S, Burns KD (2004) Tubular and interstitial cell apoptosis in the streptozotocin-diabetic rat kidney. Nephron Experimental Nephrol, 96: e77–e88.
• 23. Li W, Zheng H, Bukuru J, De Kimpe N (2004) Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol, 92: 1–21.
• 24. Li X, Liu W, Wang Q, Liu P, Deng Y, Lan T, Zhang X, Qiu B, Ning H, Huang H (2009) Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose. Mol Cell Endocrinol, 307: 157–162.
• 25. Liadis N, Murakami K, Eweida M, Elford AR, Sheu L, Gaisano HY, Hakem R, Ohashi PS, Woo M (2005) Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol, 25: 3620–3629.
• 26. Menini S, Iacobini C, Oddi G, Ricci C, Simonelli P, Fallucca S, Grattarola M, Pugliese F, Pesce C, Pugliese G (2007) Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular diseass. Diabetologia, 50: 2591–2599.
• 27. Moresco RN, Sangoi MB, De Carvalho JA, Tatsch E, Bochi GV (2013) Diabetic nephropathy: traditional to proteomic markers. Clin Chim Acta, 421: 17–30.
• 28. Mustafa HN, El Awdan SA, Hegazy GA (2013) Protective role of antioxidants on thioacetamide-induced acute hepatic encephalopathy: Biochemical and Ultrastructural study. Tissue Cell, 45: 350–362.
• 29. Nain P, Saini V, Sharma S, Nain J (2012) Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J Ethnopharmacol, 142: 65–71.
• 30. Nauta FL, Boertien WE, Bakker SJ, van Goor H, van Oeveren W, de Jong PE, Bilo H, Gansevoort RT (2011) Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care, 34: 975–981.
• 31. Nekooeian AA, Eftekhari MH, Adibi S, Rajaeifard A (2014) Effects of pomegranate seed oil on insulin release in rats with type 2 diabetes. Iran J Med Sci, 39: 130–135.
• 32. Padhy M, Kaushik S, Girish M, Mohapatra S, Shah S, Koner BC (2014) Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Clin Chim Acta, 435: 48–52.
• 33. Quezada C, Alarcon S, Jaramillo C, Munoz D, Oyarzun C,San Martin R (2013) Targeting adenosine signaling to treatment of diabetic nephropathy. Curr Drug Targets, 14: 490–496.
• 34. Salib JY, Michael HN, Eskande EF (2013) Anti-diabetic properties of flavonoid compounds isolated from Hyphaene thebaica epicarp on alloxan induced diabetic rats. Pharmacognosy Res, 5: 22–29.
• 35. Saravanan G, Leelavinothan P (2012) Effects of Syzygium cumini bark on blood glucose, plasma insulin and C-peptide in streptozotocin induced diabetic rats. Int J Endocrinol Metab, 4: 96–105.
• 36. Shaker OG, El-Shehaby A, El-Khatib M (2010) Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology, 61: 731–736.
• 37. Shehu B, Gidado A, Buratai L (2014) Hypoglycaemic, hypolipidaemic and possible toxicity of the methanolic fruit pulp extract of hyphane thebaica (L) Mart in alloxan-induced diabetic rats. J Med Applied Bioscien, 6: 1–10.
• 38. Simsek A, Tugcu V, Tasci AI (2013) New biomarkers for the quick detection of acute kidney injury. ISRN Nephrol, 2013: 394582.
• 39. Sirota JC, Walcher A, Faubel S, Jani A, McFann K, Devarajan P, Davis CL, Edelstein CL (2013) Urine IL-18, NGAL, IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation. BMC Nephrol, 14: 17.
• 40. Soler MJ, Riera M, Batlle D (2012) New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy. Exp Diabetes Res, 2012: 616313.
• 41. Suvarna KS, Suvarna SK, Layton C, Bancroft JD (2012) Bancroft’s Theory and practice of histological techniques, expert consult: Online and Print, 7: Elsevier Health Sciences, pp. 105–123.
• 42. Tramonti G, Kanwar YS (2013) Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy. Endocrine, 43: 494–503.
• 43. Van den Oever IA, Raterman HG, Nurmohamed MT, Simsek S (2010) Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm, 2010: 792393.
• 44. Venkatesh S, Madhava Reddy B, Dayanand Reddy G, Mullangi R, Lakshman M (2010) Antihyperglycemic and hypolipidemic effects of Helicteres isora roots in alloxan-induced diabetic rats: a possible mechanism of action. J Nat Med, 64: 295–304.
• 45. Wang GG, Lu XH, Li W, Zhao X, Zhang C (2011) Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats. Evid Based Complement Alternat Med, 2011: 323171.
• 46. Zheng H, Whitman SA, Wu W, Wondrak GT, Wong PK, Fang D, Zhang DD (2011) Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes, 60: 3055–3066.
• 47. Zou J, Yaoita E, Watanabe Y, Yoshida Y, Nameta M, Li H, Qu Z, Yamamoto T (2006) Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch, 448: 485–492.

Identyfikatory

DOI

10.5603/FM.2015.0106